LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 46

Search options

  1. Article ; Online: Practice of Cardiology during COVID 19 pandemic. Recommendations of the Mexican Cardiology Community.

    Sierra-Fernández, Carlos R / Alcocer-Gamba, Marco A / Buendía-Hernández, Alfonso

    Archivos de cardiologia de Mexico

    2020  Volume 90, Issue Supl, Page(s) 5–6

    Title translation La práctica de la Cardiología ante la pandemia por COVID-19. Recomendaciones de la comunidad cardiológica mexicana.
    MeSH term(s) COVID-19 ; Cardiology/organization & administration ; Coronavirus Infections/epidemiology ; Humans ; Mexico/epidemiology ; Pandemics ; Pneumonia, Viral/epidemiology
    Keywords covid19
    Language English
    Publishing date 2020-06-10
    Publishing country Mexico
    Document type Editorial
    ISSN 1665-1731
    ISSN (online) 1665-1731
    DOI 10.24875/ACM.M20000072
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Modificaciones en el estilo de vida y control de los factores de riesgo en la prevención y el tratamiento de la fibrilación auricular.

    Rodríguez-Reyes, Humberto / Asensio-Lafuente, Enrique / Cossío-Aranda, Jorge E / Borrayo-Sánchez, Gabriela / Alcocer-Gamba, Marco / Berni-Betancourd, Ana / Picos-Bovio, Eva M / Gallegos-De Luna, Carlos F / Laguna-Muñoz, César I / Corona-Martínez, Víctor A / Muñoz-Gutiérrez, Luz M / Rodríguez-Muñoz, Karla M

    Archivos de cardiologia de Mexico

    2024  

    Abstract: Atrial fibrillation (AF) is the most prevalent arrhythmia and is related with significant morbidity, mortality and costs. In spite of relevant advances in the prevention of embolic events and rhythm control, little has been done to reduce its prevalence, ...

    Title translation Lifestyle modification and risk factor control in the prevention and treatment of atrial fibrillation.
    Abstract Atrial fibrillation (AF) is the most prevalent arrhythmia and is related with significant morbidity, mortality and costs. In spite of relevant advances in the prevention of embolic events and rhythm control, little has been done to reduce its prevalence, progression and impact, since it increases with ageing as well as with common risk factors such as alcohol intake, tobacco use and stress as well as with arterial hypertension, diabetes mellitus, heart failure, sleep apnea, kidney failure, chronic pulmonary obstructive disease, ischemic heart disease and stroke, among other important comorbidities. Fortunately, new evidence suggests that lifestyle modifications and adequate risk factors and comorbidities control could be effective in primary and secondary AF prevention, especially in its paroxysmal presentations. This is why a multidisciplinary approach integrating lifestyle modifications, risk factors and comorbidities control, is necessary in conjunction with rhythm or rate control and anticoagulation. Unfortunately, that holistic approach strategy is not considered, is scarcely studied or is subtilized in general clinical practice. The present statement's objectives are to: 1) review the relationship between habits, risk factors and illnesses with AF, 2) review the individual and common physiopathology mechanisms of each one of those conditions that may lead to AF, 3) review the effect of control of habits, risk factors and co-morbidities on the control and impact of AF, and 4) supply guidelines and recommendations to start multidisciplinary and integrative AF treatment.
    Language Spanish
    Publishing date 2024-02-21
    Publishing country Mexico
    Document type English Abstract ; Journal Article
    ZDB-ID 2059019-2
    ISSN 1665-1731 ; 1665-1731
    ISSN (online) 1665-1731
    ISSN 1665-1731
    DOI 10.24875/ACM.22000236
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: A cross-sectional study on the prevalence of cardiovascular disease in elderly patients with long-term type 2 diabetes mellitus mainly attended in private clinics in Mexico. The CAPTURE study.

    Arenas-León, José L / Morales-Villegas, Enrique C / Cardona-Muñoz, Ernesto G / Alcocer-Gamba, Marco A / Ramirez-Contreras, Juan P / Contreras-Sandoval, Aleida Y / González-Galvez, Guillermo

    Diabetology & metabolic syndrome

    2023  Volume 15, Issue 1, Page(s) 258

    Abstract: Background: To estimate the contemporary prevalence of established cardiovascular disease (CVD) in adults with type 2 diabetes (T2D) in Mexico.: Methods: CAPTURE was a multinational, non-interventional, cross-sectional study across 13 countries from ... ...

    Abstract Background: To estimate the contemporary prevalence of established cardiovascular disease (CVD) in adults with type 2 diabetes (T2D) in Mexico.
    Methods: CAPTURE was a multinational, non-interventional, cross-sectional study across 13 countries from five continents. Standardized demographic and clinical data were collected from adults with T2D attending a single routine healthcare visit in primary or specialized care between December 2018 and September 2019. Data from Mexico are analyzed in this study.
    Results: Of the 9,823 patients included in the CAPTURE study, 820 (8.3%) participants were from Mexico, mainly attended in private centers (29.3% in 6 specialized diabetes treatment centers and 70.7% in 26 primary care centers). The median age was 63.0 years, 52.6% were women, the duration of diabetes was 11.8 years and the average HbA1c 7.5%. The weighted prevalence [95% CI] of CVD and atherosclerotic CVD was 36.9% [34.1-39.6] and 29.5% [26.7-32.3], respectively. Additionally, the prevalence of coronary heart disease, heart failure, peripheral arterial disease and cerebrovascular disease was 23.1% [20.6-25-7], 8.4% [6.8-10.0], 5.0% [3.5-6.5] and 3.9% [2.6-5.2], respectively. Glucose lowering drugs were used in 88.5% of patients, being metformin the most commonly drug used (79.4%), followed by sulfonylureas (26.3%). SGLT-2 inhibitors and GLP1 receptor agonists were used in 15.5% and 3.9%, respectively.
    Conclusions: In Mexico, nearly four out of ten patients with T2D mainly attended in private centers have CVD, particularly atherosclerotic CVD. Most patients were not taking glucose lowering drugs with proven CV benefit.
    Language English
    Publishing date 2023-12-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 2518786-7
    ISSN 1758-5996
    ISSN 1758-5996
    DOI 10.1186/s13098-023-01231-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: La práctica de la Cardiología ante la pandemia por COVID-19. Recomendaciones de la comunidad cardiológica mexicana

    Sierra-Fernández, Carlos R. / Alcocer-Gamba, Marco A. / Buendía-Hernández, Alfonso

    Arch Cardiol Mex

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #603307
    Database COVID19

    Kategorien

  5. Article: La práctica de la Cardiología ante la pandemia por COVID-19. Recomendaciones de la comunidad cardiológica mexicana./ Practice of Cardiology during COVID 19 pandemic. Recommendations of the Mexican Cardiology Community

    Sierra-Fernández, Carlos R / Alcocer-Gamba, Marco A / Buendía-Hernández, Alfonso

    Arch Cardiol Mex

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #32523148
    Database COVID19

    Kategorien

  6. Article ; Online: The SARS-CoV-2 (COVID-19) coronavirus pandemic: current situation and implications for Mexico.

    Escudero, Xavier / Guarner, Jeannette / Galindo-Fraga, Arturo / Escudero-Salamanca, Mara / Alcocer-Gamba, Marco A / Del-Río, Carlos

    Archivos de cardiologia de Mexico

    2020  Volume 90, Issue Supl, Page(s) 7–14

    Abstract: The Coronavirus pandemic (COVID-19) is one of the most devastating in this century. It originated in China in December 2019 caused by the SARS-Cov-2 virus, and in less than a month it had been classified as an "International Public Health Emergency". To ... ...

    Title translation La pandemia de Coronavirus SARS-CoV-2 (COVID-19): Situación actual e implicaciones para México.
    Abstract The Coronavirus pandemic (COVID-19) is one of the most devastating in this century. It originated in China in December 2019 caused by the SARS-Cov-2 virus, and in less than a month it had been classified as an "International Public Health Emergency". To date there are nearly 3 million people infected and more than 250,000 deaths caused by the disease worldwide. Initially it affects the respiratory tract with atypical pneumonia and in severe cases it produces systemic inflammation with cytokine storm that can cause rapid deterioration with circulatory and respiratory failure, coagulopathy and a lethality rate of approximately 7%. In Mexico, the first case was detected in February 2020, and to date there are 26,616 confirmed cases and 2,961 deaths throughout the country. The low number of diagnostic tests conducted in our country clearly underestimates the real incidence and impact of the disease. The most affected groups are those with risk factors such as age over 60, presence of hypertension, diabetes or cardiovascular disease. Of the confirmed cases, 15% are healthcare workers. There is no specific treatment or vaccine yet, so it is important to have hygiene, social isolation and personal protection measures. Health, social and economic consequences could have great impact in the near future.
    MeSH term(s) Age Factors ; COVID-19 ; COVID-19 Testing ; Clinical Laboratory Techniques/statistics & numerical data ; Coronavirus Infections/diagnosis ; Coronavirus Infections/epidemiology ; Coronavirus Infections/prevention & control ; Health Personnel/statistics & numerical data ; Humans ; Incidence ; Mexico/epidemiology ; Pandemics/prevention & control ; Personal Protective Equipment ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/prevention & control ; Risk Factors
    Keywords covid19
    Language English
    Publishing date 2020-06-10
    Publishing country Mexico
    Document type Journal Article
    ISSN 1665-1731
    ISSN (online) 1665-1731
    DOI 10.24875/ACM.M20000064
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Return to exercise after COVID-19. Statement of the Mexican Society of Cardiology

    Cerón-Enriquez, Norma / García-Saldivia, Marianna A / Lara-Vargas, Jorge A / Núñez-Urquiza, Juan P / Alonso-Sánchez, J Jesús / Silva-Torres, J Jesús / Pérez-Gámez, Juan C / Pacheco-Beltrán, Nancy / Alcocer-Gamba, Marco A

    Archivos de cardiologia de Mexico

    2021  Volume 91, Issue Suplemento COVID, Page(s) 102–109

    Abstract: The coronavirus disease 2019 (COVID-19) was declared a pandemic on March 11, 2020; one consequence has been the increase in sedentary lifestyle and reduction of sports activity. Exercise benefits the immune defense system especially in older adults; it ... ...

    Title translation Retorno al ejercicio después de COVID-19. Posicionamiento de la Sociedad Mexicana de Cardiología
    Abstract The coronavirus disease 2019 (COVID-19) was declared a pandemic on March 11, 2020; one consequence has been the increase in sedentary lifestyle and reduction of sports activity. Exercise benefits the immune defense system especially in older adults; it is recommended to keep a distance of 1.5 meters between people, and if walking or jogging is carried out, the space must be up to 5 and 10 meters respectively. The reported cases are mostly mild up to 80% and can be critical in up to 4.7%; the risk factors are well known, hypertension, diabetes and previous heart disease. Severe or critical cases present as symptoms of acute respiratory distress syndrome, and in the case of cardiovascular disease, they mainly occur as myopericarditis, acute coronary syndromes, cardiogenic shock, thrombotic events, among others. Returning to exercise after recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is always recommended, however it will depend on the clinical picture what measures should be taken prior to its onset, and it is in moderate cases and especially in the severe ones where the evaluation and prescription prior to returning to exercise or sport should be guided by medical personnel experts in cardiopulmonary rehabilitation, especially in athletes.
    MeSH term(s) COVID-19 ; Cardiac Rehabilitation ; Cardiology ; Humans ; Mexico ; Pandemics ; Return to Sport
    Language Spanish
    Publishing date 2021-12-20
    Publishing country Mexico
    Document type Journal Article
    ZDB-ID 2059019-2
    ISSN 1665-1731 ; 1665-1731
    ISSN (online) 1665-1731
    ISSN 1665-1731
    DOI 10.24875/ACM.20000507
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Documento de consenso sobre el uso de iSGLT2 en pacientes con enfermedad renal crónica y diabetes.

    Correa-Rotter, Ricardo / Rosas-Guzmán, Juan / Méndez-Durán, Antonio / Sebastián-Díaz, Mario A / Díaz-Avendaño, Odette Del C / Mehta-Pravin, Roopa / Alcocer-Gamba, Marco A

    Gaceta medica de Mexico

    2021  Volume 158, Issue M2, Page(s) M1–M12

    Abstract: ... el control de la glucemia y pueden contribuir sustancialmente a retrasar la aparición o la progresión a ... no se adaptan a la realidad mexicana. Se presentan las conclusiones de un consenso realizado por especialistas ... de sodio-glucosa.: Chronic kidney disease (CKD) in the diabetic patient is mainly a consequence of long ...

    Title translation Consesus document in the use of SGLT inhibitors in patients with diabetes and chronic kidney disease.
    Abstract La enfermedad renal crónica (ERC) del paciente diabético es frecuentemente una consecuencia directa de la diabetes mellitus (DM) de larga evolución y se la conoce como nefropatía diabética. En México cerca del 50% de los pacientes en terapia sustitutiva de la función renal tienen ERC por DM, y este porcentaje podría aumentar en los próximos años. Nuevas opciones terapéuticas, combinadas con cambios en el estilo de vida, han mejorado el control de la glucemia y pueden contribuir sustancialmente a retrasar la aparición o la progresión a estadios avanzados de la ERC. Las sociedades científicas internacionales han elaborado guías clínicas para el diagnóstico y manejo de la nefropatía diabética, sin embargo, en algunos puntos estas recomendaciones no se adaptan a la realidad mexicana. Se presentan las conclusiones de un consenso realizado por especialistas mexicanos sobre diabetes y ERC, con especial énfasis en el uso de los inhibidores del cotransportador de sodio-glucosa.
    Chronic kidney disease (CKD) in the diabetic patient is mainly a consequence of long-term diabetes mellitus itself. In Mexico approximately 50% of patients on dialysis are diabetics and this will could increase in the coming years. New therapeutic options available, combined with lifestyle changes, have improved glycemic control and may contribute to delay the onset as well as the progression of CKD. International scientific societies have developed clinical guidelines for the diagnosis and management of CKD in diabetics, although in some points, these recommendations are not adapted to the Mexican reality. We hereby present the conclusions of the consensus reached by Mexican specialists on diabetic nephropathy.
    MeSH term(s) Diabetes Mellitus/epidemiology ; Humans ; Mexico/epidemiology ; Renal Dialysis ; Renal Insufficiency, Chronic/epidemiology ; Retrospective Studies
    Language English
    Publishing date 2021-12-30
    Publishing country Mexico
    Document type Journal Article
    ZDB-ID 425456-9
    ISSN 0016-3813
    ISSN 0016-3813
    DOI 10.24875/GMM.M21000595
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: COVID-19 and the renin, angiotensin, aldosterone system. A complex relationship.

    Alcocer-Díaz-Barreiro, Luis / Cossio-Aranda, Jorge / Verdejo-Paris, Juan / Odin-de-Los-Ríos, Manuel / Galván-Oseguera, Héctor / Álvarez-López, Humberto / Alcocer-Gamba, Marco A

    Archivos de cardiologia de Mexico

    2020  Volume 90, Issue Supl, Page(s) 19–25

    Abstract: The COVID-19 pandemic has had major negative health, psychological, social and economic repercussions for individuals, families, communities, countries and for humanity in general. The interrelation with age and the presence of chronic non-communicable ... ...

    Title translation COVID-19 y el sistema renina, angiotensina, aldosterona. Una relación compleja.
    Abstract The COVID-19 pandemic has had major negative health, psychological, social and economic repercussions for individuals, families, communities, countries and for humanity in general. The interrelation with age and the presence of chronic non-communicable diseases (hypertension, diabetes, obesity, smoking) seems to go further than what would be explained by the prevalence and distribution of both. The drugs that act on the renin-angiotensin-aldosterone system are in many cases the backbone for the management of these diseases, it has been known for a long time that these drugs significantly increase the expression of receptors for angiotensin conversion enzyme type 2 in the lung tissue. This fact, together with the knowledge that the route of entry of the virus into the cell is precisely the ACE-2 receptor, initiated a hypothesis, based on very low-quality evidence, which quickly became generalized in the media, that the use of these drugs could be negative and that they should be interrupted immediately. The response of practically all Scientific Societies was almost immediate, with the precise indication that treatment with these drugs should not be discontinued, since the evidence of their usefulness is based on very solid and high-quality evidence. Simultaneously, a different hypothesis also appeared, also based on very preliminary evidence, that these drugs are not only harmful but also beneficial, however these medicaments are not yet accepted as agents for the prevention or treatment of this disease or its complications. This review reports current knowledge on the relationship between COVID-19 and SRAA.
    MeSH term(s) Animals ; Coronavirus Infections/drug therapy ; Coronavirus Infections/epidemiology ; Coronavirus Infections/virology ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Humans ; Pandemics ; Peptidyl-Dipeptidase A/metabolism ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/virology ; Renin-Angiotensin System/drug effects ; Renin-Angiotensin System/physiology ; Risk Factors
    Chemical Substances Peptidyl-Dipeptidase A (EC 3.4.15.1) ; angiotensin converting enzyme 2 (EC 3.4.17.-)
    Keywords covid19
    Language English
    Publishing date 2020-05-06
    Publishing country Mexico
    Document type Journal Article ; Review
    ISSN 1665-1731
    ISSN (online) 1665-1731
    DOI 10.24875/ACM.M20000063
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Patient care protocols in cardiac catheterization rooms during the COVID-19 outbreak.

    Eid-Lidt, Guering / Cortes-Lawrenz, Jorge / López-Cuellar, Julio / Leiva-Pons, José L / Alcocer-Gamba, Marco A / Farjat-Pasos, Julio I / García-Alcántara, Juan A

    Archivos de cardiologia de Mexico

    2020  Volume 90, Issue Supl, Page(s) 45–49

    Title translation Protocolos de atención de pacientes en salas de cateterismo cardiaco durante el brote de COVID-19.
    MeSH term(s) COVID-19 ; Cardiac Catheterization/methods ; Cardiac Catheterization/standards ; Coronavirus Infections/epidemiology ; Coronavirus Infections/prevention & control ; Coronavirus Infections/transmission ; Disease Outbreaks ; Humans ; Pandemics/prevention & control ; Patient Care/methods ; Patient Care/standards ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/prevention & control ; Pneumonia, Viral/transmission ; Risk Factors
    Keywords covid19
    Language English
    Publishing date 2020-06-10
    Publishing country Mexico
    Document type Journal Article
    ISSN 1665-1731
    ISSN (online) 1665-1731
    DOI 10.24875/ACM.M20000066
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top